Exact Mass: 454.0923

Exact Mass Matches: 454.0923

Found 34 metabolites which its exact mass value is equals to given mass value 454.0923, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-

4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-

C23H18O10 (454.09)


   

7-O-galloyl-(+)-catechin

7-O-galloyl-(+)-catechin

C23H18O10 (454.09)


   

Swerpunilactone B

Swerpunilactone B

C23H18O10 (454.09)


   

Oprea1_465736

Oprea1_465736

C23H18O10 (454.09)


   

2,4-diacetoxy-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-benzo[b]carbazole-5-carbonitrile|Kinamycin D|Ninamycin D

2,4-diacetoxy-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1,2,3,4,6,11-hexahydro-benzo[b]carbazole-5-carbonitrile|Kinamycin D|Ninamycin D

C22H18N2O9 (454.1012)


   

Kaempferol tetraacetate

Flavone, 3,4,5,7-tetrahydroxy-, tetraacetate (7CI,8CI); 3,5,7-Tris(acetyloxy)-2-[4-(acetyloxy)phenyl]-4H-1-benzopyran-4-one

C23H18O10 (454.09)


   

Scutellarein tetraacetate

4,5,6,7-Tetrahydroxyflavone tetraacetate

C23H18O10 (454.09)


   

7-acetyloxy-2-(3,4-diacetyloxyphenyl)-4-oxochromen-5-yl acetate

4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-

C23H18O10 (454.09)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.188 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.193

   

Cys Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C14H22N4O9S2 (454.0828)


   

Cys Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C14H22N4O9S2 (454.0828)


   

Cys Asp Asp Cys

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carboxy-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H22N4O9S2 (454.0828)


   

Asp Cys Cys Asp

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C14H22N4O9S2 (454.0828)


   

Asp Cys Asp Cys

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C14H22N4O9S2 (454.0828)


   

Asp Asp Cys Cys

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C14H22N4O9S2 (454.0828)


   

Phe-Phe4Cl-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)-3-(4-chlorophenyl)propanoic acid

C23H19ClN2O6 (454.0932)


   

Phe4Cl-Phe-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C23H19ClN2O6 (454.0932)


   

3-[(4-Methyl-3-nitrophenyl)sulfonyl]-2-(2,4,5-trimethoxyphenyl)-1 ,3-thiazolidine

3-[(4-Methyl-3-nitrophenyl)sulfonyl]-2-(2,4,5-trimethoxyphenyl)-1 ,3-thiazolidine

C19H22N2O7S2 (454.0868)


   
   

Quinolinium,1-ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]-, iodide (1:1)

Quinolinium,1-ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]-, iodide (1:1)

C23H23IN2 (454.0906)


   

1,1-Diethyl-2,2-cyanine iodide

1,1-Diethyl-2,2-cyanine iodide

C23H23IN2 (454.0906)


   

1,1′-Diethyl-4,4′-cyanine iodide

1,1′-Diethyl-4,4′-cyanine iodide

C23H23IN2 (454.0906)


   

TRI-P-TOLYLSULFONIUM TRIFLATE

TRI-P-TOLYLSULFONIUM TRIFLATE

C22H21F3O3S2 (454.0884)


   

1-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine

1-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine

C19H22N2O7S2 (454.0868)


   

4-[4-[(5Z)-5-[(4-ethylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

4-[4-[(5Z)-5-[(4-ethylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

C23H22N2O4S2 (454.1021)


   

2-[[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

2-[[4-(3,4-dimethoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

C19H17F3N4O4S (454.0923)


   

[(E)-4-[3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl]-2-methylbut-2-enyl] hydrogen sulate

[(E)-4-[3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl]-2-methylbut-2-enyl] hydrogen sulate

C20H22O10S (454.0934)


   

4,5,6,7-Tetrahydroxyflavone tetraacetate

Flavone, 4,5,6,7-tetrahydroxy-, tetraacetate

C23H18O10 (454.09)


   

ML349

ML349

C23H22N2O4S2 (454.1021)


ML349 is a potent and specific acyl protein thioesterase 2(APT2)/lysophospholipase 2 (LYPLA2) inhibitor with a Ki of 120 nM. ML349 is also an inhibitor of LYPLA2 with an IC50 of 144 nM[1][2].

   

4-(acetyloxy)-5-cyano-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-2-yl acetate

4-(acetyloxy)-5-cyano-1,3,7-trihydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-2-yl acetate

C22H18N2O9 (454.1012)


   

7-(3,4-dihydroxyphenyl)-4,6-dihydroxy-8-oxo-6,7-dihydro-5h-naphthalen-2-yl 3,4,5-trihydroxybenzoate

7-(3,4-dihydroxyphenyl)-4,6-dihydroxy-8-oxo-6,7-dihydro-5h-naphthalen-2-yl 3,4,5-trihydroxybenzoate

C23H18O10 (454.09)


   

(1r,2r,3r,4s)-1-(acetyloxy)-2,4,9-trihydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-3-yl acetate

(1r,2r,3r,4s)-1-(acetyloxy)-2,4,9-trihydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-3-yl acetate

C22H18N2O9 (454.1012)


   

(6s,7r)-7-(3,4-dihydroxyphenyl)-4,6-dihydroxy-8-oxo-6,7-dihydro-5h-naphthalen-2-yl 3,4,5-trihydroxybenzoate

(6s,7r)-7-(3,4-dihydroxyphenyl)-4,6-dihydroxy-8-oxo-6,7-dihydro-5h-naphthalen-2-yl 3,4,5-trihydroxybenzoate

C23H18O10 (454.09)


   

(1r,2r,3r,4s)-1,3-bis(acetyloxy)-11-(diazyn-1-ium-1-yl)-2,4,10-trihydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

(1r,2r,3r,4s)-1,3-bis(acetyloxy)-11-(diazyn-1-ium-1-yl)-2,4,10-trihydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

C22H18N2O9 (454.1012)